Empagliflozin as Add-On to Metformin in Patients With Type 2 Diabetes: A 24-Week, Randomized, Double-Blind, Placebo-Controlled Trial

DSpace Repository

Empagliflozin as Add-On to Metformin in Patients With Type 2 Diabetes: A 24-Week, Randomized, Double-Blind, Placebo-Controlled Trial

Author: Haering, Hans-Ulrich; Merker, Ludwig; Seewaldt-Becker, Elke; Weimer, Marc; Meinicke, Thomas; Broedl, Uli C.; Woerle, Hans J.
Tübinger Autor(en):
Häring, Hans-Ulrich
Published in: Diabetes Care (2014), Bd. 37, H. 6, S. 1650-1659
Verlagsangabe: Amer Diabetes Assoc
Language: English
Full text: http://dx.doi.org/10.2337/dc13-2105
ISSN: 0149-5992
DDC Classifikation: 610 - Medicine and health
Dokumentart: Artikel
Show full item record

This item appears in the following Collection(s)